Evaluation of HPMPC therapy for primary and recurrent genital herpes in mice and guinea pigs-Reference-Cited by-同舟云学术

Evaluation of HPMPC therapy for primary and recurrent genital herpes in mice and guinea pigs

Published:1993-05 Issue:1 Volume:21 Page:59-72
ISSN:0166-3542
Container-title:Antiviral Research
language:en
Short-container-title:Antiviral Research

Author:

Bravo Fernando J.,Stanberry Lawrence R.,Kier Ann B.,Vogt Peggy E.,Kern Earl R.

Publisher

Elsevier BV

Subject

Virology,Pharmacology

Reference26 articles.

1. Antibody response, recurrence patterns and subsequent herpes simplex virus type 2 (HSV-2) re-infection following initial HSV-2 infection of guinea pigs: Effects of acyclovir;Bernstein;J. Gen. Virol.,1986

2. Synthesis and antiviral activity of nucleotide analogues bearing the (5)-(3-hydroxy-2-phosphonylmethoxy) propyl moiety attached to adenine (HPMPA) guanine (HPMPG), and cytosine (HPMPC);Bronson,1989

3. Synthesis and antiviral activity of nucleotide analogue (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl] cytosine;Bronson;J. Med. Chem.,1989

4. A trial of topical acyclovir in genital herpes simplex virus infections;Corey;N. Engl. J. Med.,1982

5. Antiviral activity of phosphonylmethoxyalkyl derivatives of purine and pyrimidines;De Clercq;Antiviral Res.,1987

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preclinical Toxicology of Vaccines;A Comprehensive Guide to Toxicology in Nonclinical Drug Development;2024

2. Preclinical Toxicology of Vaccines 1 1Disclaimer: The findings and conclusions in this chapter have not been formally disseminated by the Food and Drug Administration and should not be construed to represent any Agency determination or policy.;A Comprehensive Guide to Toxicology in Nonclinical Drug Development;2017

3. Preclinical Toxicology of Vaccines;A Comprehensive Guide to Toxicology in Preclinical Drug Development;2013

4. Guinea Pigs as Experimental Models;The Laboratory Rabbit, Guinea Pig, Hamster, and Other Rodents;2012

5. Cytomegalovirus antivirals and development of improved animal models;Expert Opinion on Drug Metabolism & Toxicology;2011-09